Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Debt / NOTE 1.000% 9/1
-
Number of holders
-
20
-
Total 13F principal, excl. options
-
239,870,400
-
Principal change
-
+23,325,000
-
Total reported value, excl. options
-
$646,058,860
-
Value change
-
+$66,870,578
-
Number of buys
-
7
-
Number of sells
-
9
-
Price
-
$2.69
Institutional Holders of UNITED THERAPEUTICS CORP DEL - NOTE 1.000% 9/1 as of Q3 2014
As of 30 Sep 2014 UNITED THERAPEUTICS CORP DEL - NOTE 1.000% 9/1 had 20 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $239,870,400 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included Castle Creek Arbitrage, LLC, WOLVERINE ASSET MANAGEMENT LLC, CAMDEN ASSET MANAGEMENT L P /CA, Citadel Advisors LLC, QVT Financial LP, BASSO CAPITAL MANAGEMENT L.P., WHITEBOX ADVISORS LLC, BlueMountain Capital Management, LLC, LAZARD ASSET MANAGEMENT LLC, and Jefferies Group LLC.
This table shows 20 bond principal holders of the security as of 30 Sep 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.